Centogene N.V.
Index- P/E- EPS (ttm)-2.42 Insider Own20.83% Shs Outstand22.44M Perf Week10.06%
Market Cap18.63M Forward P/E- EPS next Y-1.34 Insider Trans0.00% Shs Float10.13M Perf Month-18.34%
Income-54.60M PEG- EPS next Q-0.38 Inst Own66.80% Short Float / Ratio0.32% / 1.89 Perf Quarter-43.26%
Sales139.40M P/S0.13 EPS this Y-104.20% Inst Trans-0.82% Short Interest0.03M Perf Half Y-72.22%
Book/sh1.50 P/B0.53 EPS next Y11.90% ROA-46.50% Target Price4.25 Perf Year-88.42%
Cash/sh1.89 P/C0.42 EPS next 5Y- ROE-124.50% 52W Range0.68 - 7.37 Perf YTD-84.70%
Dividend- P/FCF- EPS past 5Y-50.60% ROI-83.10% 52W High-89.15% Beta-
Dividend %- Quick Ratio2.40 Sales past 5Y47.00% Gross Margin14.80% 52W Low17.65% ATR0.08
Employees808 Current Ratio2.50 Sales Q/Q3.00% Oper. Margin-38.30% RSI (14)39.92 Volatility14.63% 7.96%
OptionableNo Debt/Eq1.32 EPS Q/Q22.30% Profit Margin-35.80% Rel Volume3.48 Prev Close0.76
ShortableYes LT Debt/Eq1.12 Earnings- Payout- Avg Volume17.25K Price0.80
Recom1.50 SMA20-3.81% SMA50-21.14% SMA200-65.90% Volume57,397 Change4.85%
Aug-05-21Resumed Credit Suisse Outperform $14
Apr-24-20Downgrade Evercore ISI Outperform → In-line $21
Dec-03-19Initiated Robert W. Baird Outperform
Dec-02-19Initiated Evercore ISI Outperform
Dec-02-19Initiated BTIG Research Buy
Nov-23-22 12:59PM
Nov-21-22 06:30AM
Nov-10-22 06:30AM
Nov-03-22 06:00AM
Oct-06-22 06:00AM
08:00AM Loading…
Oct-03-22 08:00AM
Sep-01-22 06:30AM
Jul-15-22 08:15AM
Jun-27-22 04:01PM
Jun-13-22 06:30AM
Jun-02-22 05:25PM
May-25-22 05:35PM
May-23-22 06:30AM
06:30AM Loading…
May-19-22 06:30AM
May-06-22 08:01AM
Apr-28-22 06:30AM
Mar-30-22 01:00PM
Mar-24-22 06:30AM
Mar-23-22 06:30AM
Mar-17-22 06:30AM
Feb-22-22 06:30AM
Feb-08-22 06:30AM
Feb-01-22 08:24AM
Jan-20-22 06:30AM
08:00AM Loading…
Jan-04-22 08:00AM
Dec-23-21 08:00AM
Dec-20-21 08:30AM
Dec-18-21 07:17AM
Nov-24-21 08:55AM
Nov-18-21 06:30AM
Nov-04-21 06:30AM
Oct-28-21 06:30AM
Oct-19-21 07:20AM
Oct-06-21 08:00AM
Sep-30-21 07:05AM
Sep-29-21 05:05PM
Sep-07-21 04:00PM
Sep-01-21 06:30AM
Jul-27-21 06:30AM
Jun-25-21 06:30AM
Jun-22-21 06:30AM
Jun-19-21 04:34AM
Jun-16-21 08:00AM
Jun-15-21 08:14AM
Jun-09-21 04:30PM
Jun-07-21 07:23AM
Jun-04-21 10:07AM
Jun-02-21 06:31AM
Jun-01-21 06:30AM
May-26-21 06:30AM
May-18-21 06:30AM
May-10-21 06:30AM
May-07-21 06:32AM
May-06-21 06:30AM
May-05-21 06:30AM
May-04-21 11:04AM
May-03-21 11:50AM
Apr-20-21 01:19AM
Apr-19-21 03:12AM
Apr-15-21 06:30AM
Apr-14-21 06:30AM
Apr-08-21 06:30AM
Mar-09-21 06:30AM
Feb-18-21 01:59AM
Dec-18-20 10:02AM
Dec-16-20 07:03AM
Dec-09-20 06:30AM
Dec-08-20 06:30AM
Nov-25-20 06:30AM
Nov-13-20 11:30AM
Nov-09-20 04:00AM
Nov-05-20 02:00AM
Oct-20-20 08:17AM
Oct-19-20 06:30AM
Oct-14-20 08:14AM
Sep-28-20 06:30AM
Sep-25-20 06:32AM
Sep-23-20 08:05AM
Sep-16-20 08:30AM
Sep-10-20 08:15AM
Sep-03-20 06:30AM
Sep-01-20 08:30AM
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.